Direkt zum Inhalt
Merck
  • Opposing changes in thoracic and abdominal aortic biomechanical properties in rodent models of vascular calcification and hypertension.

Opposing changes in thoracic and abdominal aortic biomechanical properties in rodent models of vascular calcification and hypertension.

American journal of physiology. Heart and circulatory physiology (2014-05-20)
Omar Z Ameer, Ibrahim M Salman, Alberto P Avolio, Jacqueline K Phillips, Mark Butlin
ZUSAMMENFASSUNG

This study investigated the effects of hypertension on regional aortic biomechanical and structural properties in three rat models of vascular calcification: the hypertensive Lewis polycystic kidney (LPK; n = 13) model of chronic kidney disease, spontaneously hypertensive rats (SHRs; n = 12), and calcification in normotensive Lewis rats induced by vitamin D3 and nicotine (VDN; n = 8). Lewis and Wistar-Kyoto rats were controls. Thoracic and abdominal aortic stiffness parameters were assessed by tensile testing. In models where aortic stiffness differences compared with controls existed in both thoracic and abdominal segments, an additional cohort was quantified by histology for thoracic and abdominal aortic elastin, collagen, and calcification. LPK and VDN animals had higher thoracic breaking strain than control animals (P < 0.01 and P < 0.05, respectively) and lower energy absorption within the tensile curve of the abdominal aorta (P < 0.05). SHRs had a lower abdominal breaking stress than Wistar-Kyoto rats. LPK and VDN rats had more elastic lamellae fractures than control rats (P < 0.001), which were associated with calcium deposition (thoracic R = 0.37, P = 0.048; abdominal: R = 0.40, P = 0.046). LPK rats had higher nuclear density than control rats (P < 0.01), which was also evident in the thoracic but not abdominal aorta of VDN rats (P < 0.01). In LPK and VDN rats, but not in control rats, media thickness and cross-sectional area were at least 1.5-fold greater in thoracic than abdominal regions. The calcification models chronic kidney disease and induced calcification in normotension caused differences in regional aortic stiffness not seen in a genetic form of hypertension. Detrimental abdominal aortic remodeling but lower stiffness in the thoracic aorta with disease indicates possible compensatory mechanisms in the proximal aorta.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Kollagen aus menschlicher Placenta, Bornstein and Traub Type IV, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Kollagen, Typ I -Lösung aus Rattenschwanz, BioReagent, suitable for cell culture, sterile-filtered
Supelco
Cholecalciferol (Vitamin D3), Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Kollagen aus Kalbshaut, Bornstein and Traub Type I, solid, BioReagent, suitable for cell culture
Sigma-Aldrich
Kollagen aus menschlicher Placenta, Bornstein and Traub Type IV, powder
Sigma-Aldrich
Cholecalciferol, ≥98% (HPLC)
Sigma-Aldrich
Kollagen aus Rattenschwanz, Bornstein and Traub Type I, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Kollagen aus Achillessehne vom Rind, powder, suitable for substrate for collagenase
Sigma-Aldrich
Urethan, ≥99%
Sigma-Aldrich
Kollagen aus chicken sternal cartilage, Type II (Miller), powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Kollagen aus Kalbshaut, Bornstein and Traub Type I, (0.1% solution in 0.1 M acetic acid), aseptically processed, BioReagent, suitable for cell culture
Sigma-Aldrich
Kollagen Typ IV aus human cell culture, Bornstein and Traub Type IV, 0.3 mg/mL, sterile-filtered, BioReagent, suitable for cell culture
Sigma-Aldrich
Kollagen aus menschlicher Placenta, Bornstein and Traub Type I (Sigma Type VIII), powder
Supelco
Cholecalciferol (D3), analytical standard
USP
Cholecalciferol, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Elastin from bovine neck ligament, powder
Sigma-Aldrich
Kollagen aus bovine tracheal cartilage, Bornstein and Traub Type II, powder
Supelco
Vitamin D3 solution, 1 mg/mL in ethanol, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
Urethan, ≥99.0% (GC)
Sigma-Aldrich
Kollagen aus bovine nasal septum, Bornstein and Traub Type II, powder
Cholecalciferol, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Kollagen human, Bornstein and Traub Type I, acid soluble, powder, ~95% (SDS-PAGE)
Sigma-Aldrich
Cholecalciferol, meets USP testing specifications
Sigma-Aldrich
Elastin, soluble from bovine neck ligament, salt-free, lyophilized powder
Sigma-Aldrich
Vitamin D3 solution, 100 μg/mL in ethanol, 97% (CP)
Sigma-Aldrich
Kollagen aus menschlicher Placenta, Bornstein and Traub Type III (Sigma Type X), powder
Sigma-Aldrich
Kollagen aus Engelbreth-Holm-Swarm murine sarcoma basement membrane, Type IV (Miller), lyophilized powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Kollagen aus menschlicher Placenta, Bornstein and Traub Type IV, solution, suitable for cell culture, High Performance
Sigma-Aldrich
Cholecalciferol, analytical standard
Sigma-Aldrich
Kollagen aus menschlicher Placenta, Bornstein and Traub Type V (Sigma Type IX), powder